Proposed CSF1R agonism to activate neuroprotective microglial states avoiding TREM2-dependent inflammation. Fatal mechanistic flaw—cited evidence describes CSF1R antagonist (PLX5622) effects, contradicting agonist strategy. Not developable as stated; requires complete reformulation.
No linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for CSF1R.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.